Ariel Mactavish, president of the Respiratory Interventions unit at Medtronic
(NYSE: MDT)
, announced that she is departing her post at the medtech giant.
In a post on LinkedIn, Mactavish explained her decision to depart:
“After 12 rewarding years, I have decided to leave Medtronic and I want to take the opportunity [to] share my deepest gratitude for the amazing work of our team and their unwavering commitment to our patients and customers over the last several years together,” she wrote.
Mactavish’s departure comes shortly after Medtronic announced major changes within her unit. The company said last month that it plans to exit the ventilator market.
That decision came more than a year after Medtronic said it would spin off its Patient Monitoring and Respiratory Interventions businesses, part of its Medical Surgical portfolio. Reports last year suggested that other medtech companies, including GE HealthCare and ICU Medical, and private equity firm Carlyle Group, had interest in buying the business off Medtronic.
Ultimately, Medtronic decided instead to end its ventilator business. It’s transitioning what remains of Patient Monitoring and Respiratory Interventions into one business unit called Acute Care and Monitoring (ACM). As part of this change, Bob White, the EVP and president of the Medical Surgical portfolio for Medtronic, also departed.
It remains unclear if the changes directly led to the departure of Mactavish, who offered further parting words:
“We have shared many proud moments – from the acquisition of Aircraft Medical to rejuvenating the Shiley airway portfolio, to responding to the unprecedented global pandemic and the world’s greatest moment of need,” Mactavish concluded in her LinkedIn post. “Our work together has positively affected hundreds of thousands of patients over the years – that’s something we will never forget.”